๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy

โœ Scribed by Herbert L. Bonkovsky; J. Michael Woolley


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
163 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Health-related quality of life in chroni
โœ Siew Chin Ong; Belinda Mak; Myat Oo Aung; Shu-Chuen Li; Seng-Gee Lim ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 1 views

The relationship between stages of chronic hepatitis B liver disease and health-related quality of life (HRQoL) is an important aspect of the overall management of hepatitis B virus (HBV) infection, yet is not well characterized. Consequently we sought to examine HRQoL in HBV patients, stratified by

Health-related quality of life in chroni
โœ John E. Ware Jr; Martha S. Bayliss; Michael Mannocchia; Gary L. Davis ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 1 views

Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about 40% of patients and apparent eradication of infection in 7% to 40% of patients. In this report, we d

Health-related quality of life in active
โœ Olav Dalgard; Atle Egeland; Kjell Skaug; Kostas Vilimas; Tore Steen ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 121 KB ๐Ÿ‘ 1 views

This study assessed the effect of chronic hepatitis C virus (HCV) infection on the healthrelated quality of life (HRQOL) of injecting drug users, comparing the HRQOL of injecting drug users with and without chronic HCV infection. The study included 199 injecting drug users of more than 18 years of a

Impaired health-related quality of life
โœ Raymond S. Koff ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 30 KB ๐Ÿ‘ 1 views

During the past decade, patient-based health outcomes research has become a growth industry. Its data are being merged with clinical and economic databases to inform health care decision-making. Supported by a variety of health care organizations, accrediting bodies, employers, health policy strateg